Trying to fit everything you need to know about professional ethics in one article is a nearly impossible task. But somebody’s got to do it—or at least attempt it!
Read More
The ethical practices of the pharmaceutical industry have recently come under scrutiny as never before. Here is a quick rundown of the main issues involved and what reforms have taken place, or may soon take place.
Read More
Ever since Peter Kramer wrote Listening to Prozac, we have suspected that SSRIs do more than simply treat depression; that they can make some patients “better than well.”
Read More
Both prior research and clinical lore tell us that divorced men are at especially high risk for suicide. Two new studies add to our knowledge about this issue, focusing on a particularly painful phase of the divorce process: marital separation.
Read More
Dr. Appelbaum, you are the chair of a work group of the American Psychiatric Association (APA) that focuses on the relationships between doctors and industry. Can you tell us about that group?
Read More
Dr. Aiken is the Editor in Chief of The Carlat Psychiatry Report; director of the Mood Treatment Center in North Carolina, where he maintains a private practice combining medication and therapy along with evidence-based complementary and alternative treatments; and Assistant Professor NYU Langone Department of Psychiatry. He has worked as a research assistant at the NIMH and a sub-investigator on clinical trials, and conducts research on a shoestring budget out of his private practice. Follow him on Twitter and find him on LinkedIn.
_-The-Breakthrough-Antipsychotic-That-Could-Change-Everything.jpg?1729528747 "KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg")
